Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma-Reference-Cited by-全球学者库

Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma

Published:2016-05-09 Issue:31 Volume:7 Page:49143-49155
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Su Yinghan¹²,Sun Bin²,Lin Xuejing²,Zhao Xinying³,Ji Weidan²,He Miaoxia³,Qian Haihua²,Song Xianmin³,Yang Jianmin³,Wang Jianmin³,Chen Jie³

Affiliation:

1. School of Life Science, University of Liverpool, Liverpool, L3 4PH, UK

2. Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & National Center of Liver Cancer, Second Military Medical University, Shanghai 200438, China

3. Department of Hematology & Pathology, Changhai Hospital, Second Military Medical University, Shanghai 200168, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal delivery of RNA interference by viral vectors for cancer therapy;Molecular Therapy;2023-11

2. MicroRNA Expression Profiling of Diffuse Large B-Cell Lymphoma;Molecular Biology;2023-06

3. The role of noncoding RNAs in metabolic reprogramming of cancer cells;Cellular & Molecular Biology Letters;2023-05-09

4. microRNA-221 and tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study;Annals of Medicine and Surgery;2022-01

5. LncRNA SNHG5 can Regulate the Proliferation and Migration of Diffuse Large B Cell Lymphoma Progression via Targeting miR-181-5p/XIAP;Journal of Cancer;2022